Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Daily News

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

Yael L. Maxwell

December 13, 2024

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

News Daily News

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Todd Neale

November 22, 2023

News Daily News

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Yael L. Maxwell

January 17, 2023

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

News Daily News

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

L.A. McKeown

November 01, 2021

News Conference News AHA 2020

Obesity Worsens Outcomes in COVID-19, Especially for Younger Adults

Shelley Wood

November 18, 2020

News Daily News

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Michael O'Riordan

September 22, 2020

News Daily News

Age Without Atherosclerosis: Tests May Help Elderly Skip Statins

Yael L. Maxwell

July 04, 2019

News Daily News

Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events

Michael O'Riordan

April 18, 2019

News Daily News

FOURIER Analysis: Evolocumab Delivers Consistent LDL Cholesterol-Lowering

Yael L. Maxwell

December 19, 2018

News Daily News

Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes

Michael O'Riordan

October 18, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2018

Shelley Wood

April 02, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Conference News ACC 2017

Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS

Michael O'Riordan

March 19, 2017

News Daily News

Statin Therapy Alters Composition of Coronary Plaques, Virtual Histology-IVUS Study Shows

Michael O'Riordan

April 14, 2016

Advertisement

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

Top General Cardiology and CVD Prevention News of 2023

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

Obesity Worsens Outcomes in COVID-19, Especially for Younger Adults

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Age Without Atherosclerosis: Tests May Help Elderly Skip Statins

Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events

FOURIER Analysis: Evolocumab Delivers Consistent LDL Cholesterol-Lowering

Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes

TCTMD’s Top 10 Most Popular Stories for March 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS

Statin Therapy Alters Composition of Coronary Plaques, Virtual Histology-IVUS Study Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content